Evidence map›Paper›PMID 40064412›Full record

Trial reportAmerican journal of obstetrics and gynecology2025

Preference, adherence, and acceptability of 3 nonmedicated intravaginal rings of differing external diameters: a randomized, crossover trial.

Barbara A Friedland, Jessica M Sales, Jessica Atrio, Marlena G Plagianos, J Brady Burnett-Zieman, Shakti Shetty, Nicole Roselli, Renee Rolston, Ann Gottert, Karina Avila and 5 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of obstetrics and gynecology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Barbara A FriedlandPopulation Council, Center for Biomedical Research, New York, NY. Electronic address: bfriedland@popcouncil.org.
Jessica M SalesRollins School of Public Health, Emory University, Atlanta, GA.
Jessica AtrioAlbert Einstein College of Medicine, Bronx, NY.
Marlena G PlagianosPopulation Council, Center for Biomedical Research, New York, NY.
J Brady Burnett-ZiemanPopulation Council, Center for Biomedical Research, New York, NY.
Shakti ShettyRollins School of Public Health, Emory University, Atlanta, GA.
Nicole RoselliAlbert Einstein College of Medicine, Bronx, NY; Division of Female Pelvic Medicine and Reconstructive Surgery, Bellevue Hospital/NYU Langone Medical Center, New York, NY.
Renee RolstonAlbert Einstein College of Medicine, Bronx, NY; Urogynecology and reconstructive pelvic surgery, Department of Obstetrics and Gynecology, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
Ann GottertPopulation Council, Social and Behavioral Sciences Research, Washington, DC.
Karina AvilaAlbert Einstein College of Medicine, Bronx, NY.
Irene V BrucePopulation Council, Center for Biomedical Research, New York, NY.
Caio Sant'Anna MarinhoAlbert Einstein College of Medicine, Bronx, NY.
Michelle NguyenRollins School of Public Health, Emory University, Atlanta, GA.
Ruth MerkatzPopulation Council, Center for Biomedical Research, New York, NY.
Lisa B HaddadPopulation Council, Center for Biomedical Research, New York, NY.

Funding

An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIVR01AI150360 · NIAID · POPULATION COUNCIL · PI DERBY, NINA R., FRIEDLAND, BARBARA A · 2020 to 2024
$4.7M
NIAID NIH HHS R01 AI150360
6 · The paper itself

Abstract

backgroundNo empirical data support the 54 to 58 mm external diameter of intravaginal rings currently available and in development for contraception and other indications. Understanding how external diameter affects preference, adherence, and acceptability is critical for optimizing future product development.

objectiveOur primary objectives were to determine which of 3 nonmedicated rings of differing external diameters was preferred and yielded the highest adherence. Secondary objectives were comparing acceptability, patterns of adherence, and safety of the 3 rings. STUDY

designIn an open-label, 3-way crossover trial, healthy, HIV-uninfected, monogamous, sexually active, nonpregnant, 18-year-old to 40-year-old cisgender women and their male partners in Atlanta, GA and the Bronx, NY were randomly assigned to the sequence of using 3 nonmedicated silicone rings (46 mm, 56 mm, and 66 mm external diameters) continuously for approximately 30 days each (90 days total; November 2021 to December 2022). We tested whether end-of-study preference for any of the 3 rings was greater than 0.33 (binomial proportion, exact test). We used mixed-effect regression models with random intercepts by participants to compare adherence (ring never out for more than 30 minutes in 24 hours) and probability of removals (including reasons for removal), expulsions, and the ring being out of the vagina all day, per ring, per day of use with the 56-mm ring as the reference group and to compare scores on a novel 19-item acceptability scale with items related to ease and experience of use and impact on sex.

resultsOf 24 women, 23 completed the study (median age: 26.7 years [standard deviation: 3.78]). Most were college graduates (92%), White (63%), non-Hispanic (79%), single (79%), and nulliparous (92%). At the end of the study, 59% preferred the smallest (46 mm) ring versus 18% each for the 56-mm and 66-mm rings (P=.0045). The proportion of participants who were adherent did not differ by ring (46 mm, 78%; 56 mm, 75%; 66 mm, 59%; P=.30); however, odds of expulsion were higher for the 46-mm (odds ratio: 5.72; 95% confidence interval: 1.25-26.1) and 66-mm (odds ratio: 25.9; 95% confidence interval: 6.11-109) rings than for the 56-mm ring. The 66-mm ring also had greater odds of being out (removal or expulsion, any length of time) than the 56-mm ring (odds ratio: 6.50; 95% confidence interval: 3.46-12.2). Mean acceptability scale scores were identical (4.54/5) for the 46-mm and 56-mm (smallest and medium) rings and significantly higher than for the largest, 66-mm ring (3.94/5; P<.001).

conclusionAlthough the 46-mm ring was preferred by more women and had higher rates of adherence compared to the other 2 rings, the 56-mm ring was rated as equally acceptable with significantly fewer reports of expulsions/removals compared to the other 2 rings. These data confirm that the current 54 to 58 mm diameter of vaginal rings on the market and in development is acceptable and performs well. Future studies should explore the effect of other mechanical attributes, such as compressibility, on preference, adherence, and acceptability, as well as investigating ring characteristics in other populations.

Indexed as

Contraceptive Devices, FemalePatient CompliancePatient PreferenceAdolescentAdultCross-Over StudiesEquipment DesignFemaleHumansMaleYoung Adult

Identifiers

PMID40064412
PMCPMC12354028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.